Proprietary pharmacists' and doctors' relationships with companies
Proprietary pharmacists’ and doctors’ relationships with companies comprised by the medicinal cannabis pilot programme
Proprietary pharmacists (also called pharmacy owners) and doctors who want to establish a relationship with a company comprised by the pilot programme must notify their relationships to the Danish Medicines Agency or be granted permission by the Danish Medicines Agency to be connected with companies.
Companies comprised by the medicinal cannabis pilot programme are required to give certain information to proprietary pharmacists and doctors with which they establish a relationship. The companies also have a duty to inform the Danish Medicines Agency of which proprietary pharmacists and doctors they establish relationships with.
These rules are intended to promote unbiased prescribing, use and dispensing of cannabis end-products. In formulating the rules, regard has also been paid to ensuring the availability of cannabis products.
The Danish Medicines Agency publishes a list of proprietary pharmacists and doctors who have notified a relationship or received permission to have a relationship with a company comprised by the pilot programme.
The Danish Medicines Agency also publishes a list of companies comprised by the pilot programme or the scheme for cultivation, production, etc. of medicinal cannabis. These companies are also comprised by the rules on relationships.